Clindamycin Phosphate and Tretinoin

Actavis Pharma, Inc.🇺🇸 United States

FDA Page

Effective Date: Feb 27, 2023
Approval ID: 79e1c8f6-59cd-4efa-9efa-0762d4b1a10c
Products: 1 registered
Version: 13

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use clindamycin phosphate and tretinoin gel 1.2% / 0.025% safely and effectively. See full prescribing information for clindamycin phosphate and tretinoin gel 1.2% / 0.025%. CLINDAMYCIN PHOSPHATE and TRETINOIN Gel 1.2% / 0.025%, for topical use only Initial U.S. Approval: 2006

Quick Stats

Total Products1

Labelers2

Label Sections32

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.